BRPI0419105B8 - - Google Patents

Info

Publication number
BRPI0419105B8
BRPI0419105B8 BRPI0419105A BRPI0419105B8 BR PI0419105 B8 BRPI0419105 B8 BR PI0419105B8 BR PI0419105 A BRPI0419105 A BR PI0419105A BR PI0419105 B8 BRPI0419105 B8 BR PI0419105B8
Authority
BR
Brazil
Application number
Other languages
Portuguese (pt)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BRPI0419105B1 publication Critical patent/BRPI0419105B1/pt
Publication of BRPI0419105A publication Critical patent/BRPI0419105A/pt
Publication of BRPI0419105B8 publication Critical patent/BRPI0419105B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0419105-6A 2004-10-01 2004-10-01 usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno BRPI0419105A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2004/000189 WO2006037194A1 (en) 2004-10-01 2004-10-01 Use of caryophyllenes in the manufacture of medicaments and treatment of bodily conditions of inflammation and inflammatory pain

Publications (3)

Publication Number Publication Date
BRPI0419105B1 BRPI0419105B1 (pt) 2006-04-13
BRPI0419105A BRPI0419105A (pt) 2007-12-11
BRPI0419105B8 true BRPI0419105B8 (US06903085-20050607-C00075.png) 2021-05-25

Family

ID=36142256

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0419105-6A BRPI0419105A (pt) 2004-10-01 2004-10-01 usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno
BR122016029094-8A BR122016029094B1 (pt) 2004-10-01 2004-10-01 Composição farmacêutica anti-inflamatória

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR122016029094-8A BR122016029094B1 (pt) 2004-10-01 2004-10-01 Composição farmacêutica anti-inflamatória

Country Status (9)

Country Link
US (1) US20080280996A1 (US06903085-20050607-C00075.png)
EP (1) EP1809268B1 (US06903085-20050607-C00075.png)
JP (1) JP2008514649A (US06903085-20050607-C00075.png)
AR (1) AR048806A1 (US06903085-20050607-C00075.png)
AT (1) ATE518531T1 (US06903085-20050607-C00075.png)
BR (2) BRPI0419105A (US06903085-20050607-C00075.png)
CA (1) CA2577219A1 (US06903085-20050607-C00075.png)
MX (1) MX2007002116A (US06903085-20050607-C00075.png)
WO (1) WO2006037194A1 (US06903085-20050607-C00075.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
WO2008144880A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
JP2012077002A (ja) * 2010-09-30 2012-04-19 Oita Univ ATL及びHTLV−1関連炎症疾患をターゲットとしたNF−κB亢進抑制剤及びその用途
US20150051299A1 (en) * 2012-03-19 2015-02-19 Ariel-University Research And Development Company, Ltd. Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists
KR101477552B1 (ko) * 2012-12-07 2014-12-30 세명대학교 산학협력단 유제놀 유도체를 함유하는 아토피성 피부염의 치료용 약제학적 조성물 및 그 제조방법
CN107530318A (zh) 2015-03-02 2018-01-02 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US10039740B2 (en) * 2015-10-23 2018-08-07 Primus Pharmaceuticals, Inc. Therapeutic combinations of sesquiterpenes and flavonoids
US10456365B2 (en) * 2016-03-25 2019-10-29 Primus Pharmaceuticals, Inc. Methods and formulations for supporting and promoting bone health
US20180049994A1 (en) * 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
EP3500282A4 (en) * 2016-08-19 2020-03-25 Aurea Biolabs Private Limited ANTI-INFLAMMATORY COMPOSITION FOR THE TREATMENT OF ACUTE JOINT INFLAMMATION AND PREPARATION METHOD THEREOF
KR102043893B1 (ko) * 2018-01-05 2019-11-12 인제대학교 산학협력단 알파-휴물렌(alpha-Humulene)을 유효성분으로 포함하는 소화기계 점막 관련 질환 예방 또는 치료용 조성물
KR102040810B1 (ko) 2018-01-31 2019-11-05 인제대학교 산학협력단 알파-휴물렌을 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987008A (en) 1971-12-17 1976-10-19 Celanese Corporation Flame retardant polyester
NL9100688A (nl) 1991-04-19 1992-11-16 Tno Toepassing van terpenoide verbindingen in de land- of tuinbouw alsmede voor de bereiding van preparaten voor het bestrijden van witte vliegsoorten.
US5314693A (en) 1992-02-07 1994-05-24 Kioritz Corporation Pest control chemicals against pine wood nematodes
JPH07215846A (ja) * 1994-01-28 1995-08-15 Takeda Chem Ind Ltd 抗アレルギー剤
CA2342403A1 (en) 2001-03-28 2002-09-28 Jean Legault Sesquiterpene derivatives as anticancer agents
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
CA2356438A1 (en) * 2001-09-05 2003-03-05 Andre Pichette Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers
EP1587482A4 (en) * 2003-01-31 2010-08-25 Technion Res & Dev Foundation ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF
JP2005206520A (ja) * 2004-01-22 2005-08-04 Univ Kinki アテローム性動脈硬化抑制剤ならびにこれを含む食品および医薬

Also Published As

Publication number Publication date
EP1809268B1 (en) 2011-08-03
CA2577219A1 (en) 2006-04-13
BR122016029094B1 (pt) 2021-10-13
BRPI0419105A (pt) 2007-12-11
JP2008514649A (ja) 2008-05-08
AR048806A1 (es) 2006-05-31
WO2006037194A1 (en) 2006-04-13
EP1809268A1 (en) 2007-07-25
MX2007002116A (es) 2007-10-16
ATE518531T1 (de) 2011-08-15
US20080280996A1 (en) 2008-11-13
BRPI0419105B1 (pt) 2006-04-13

Similar Documents

Publication Publication Date Title
BE2024C508I2 (US06903085-20050607-C00075.png)
BE2022C549I2 (US06903085-20050607-C00075.png)
BE2024C511I2 (US06903085-20050607-C00075.png)
BE2020C513I2 (US06903085-20050607-C00075.png)
BE2020C517I2 (US06903085-20050607-C00075.png)
BE2016C014I2 (US06903085-20050607-C00075.png)
BE2015C041I2 (US06903085-20050607-C00075.png)
BE2015C038I2 (US06903085-20050607-C00075.png)
BE2015C014I2 (US06903085-20050607-C00075.png)
BE2014C071I2 (US06903085-20050607-C00075.png)
BE2014C064I2 (US06903085-20050607-C00075.png)
BE2014C063I2 (US06903085-20050607-C00075.png)
BE2014C010I2 (US06903085-20050607-C00075.png)
BE2014C014I2 (US06903085-20050607-C00075.png)
BE2013C071I2 (US06903085-20050607-C00075.png)
BE2015C065I2 (US06903085-20050607-C00075.png)
BR122015024347A2 (US06903085-20050607-C00075.png)
BRPI0508002A (US06903085-20050607-C00075.png)
JP2005184003A5 (US06903085-20050607-C00075.png)
BE2015C012I2 (US06903085-20050607-C00075.png)
BE2015C033I2 (US06903085-20050607-C00075.png)
JP2005296605A5 (US06903085-20050607-C00075.png)
BE2015C011I2 (US06903085-20050607-C00075.png)
BE2014C002I2 (US06903085-20050607-C00075.png)
JP2005000656A5 (US06903085-20050607-C00075.png)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2326 DE 04/08/2015.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REF. RPI 2378 DE 02/08/2016, DEVIDO A INCORRECAO NA JUNTADA, EM FORMATO DIGITAL, DOS DOCUMENTOS ENCAMINHADOS PELA ANVISA.

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/10/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: "INPI NO 52402.007437/2022-69 ORIGEM: 7A VARA CIVEL FEDERAL DE SAO PAULO PROCESSO NO: 5003067-27.2022.4.03.6101 SUBJUDICE COM PEDIDO DE ANTECIPACAO DE TUTELA AUTOR: LUIZ FRANCISCO PIANOWSKI REU(S): ACHE LABOTATORIOS FARMACEUTICOS S/A E INSTITUTONACIONAL DA PROPRIEDADE INTELECTUAL"